Revolution Medicines Inc - ESG Rating & Company Profile powered by AI
The Sustainability rating for Revolution Medicines Inc represents its reporting of the UN Sustainable Development Goals. Comprehensive Sustainability assessment of Revolution Medicines Inc can be accessed by registering for free. This ESG rating covers 17 United Nations Sustainable Development Goals including: 'Quality Education', 'Climate Action' and 'Peace, Justice & Strong Institutions'.
Revolution Medicines Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 1.3, social score of 2.3 and governance score of 2.7.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | Revolution Medicines Inc | 2.1 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Revolution Medicines Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Revolution Medicines Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Revolution Medicines Inc report the average age of the workforce?
Sign up for free to unlockDoes Revolution Medicines Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Revolution Medicines Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Revolution Medicines Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Revolution Medicines Inc offer flexible work?
Sign up for free to unlockDoes Revolution Medicines Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Revolution Medicines Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Revolution Medicines Inc conduct supply chain audits?
Sign up for free to unlockDoes Revolution Medicines Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Revolution Medicines Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Revolution Medicines Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Revolution Medicines Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Revolution Medicines Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Revolution Medicines Inc disclose water use targets?
Sign up for free to unlockDoes Revolution Medicines Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Revolution Medicines Inc have a product recall in the last two years?
Sign up for free to unlockDoes Revolution Medicines Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Revolution Medicines Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Revolution Medicines Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Revolution Medicines Inc disclose parental leave metrics?
Sign up for free to unlockDoes Revolution Medicines Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Revolution Medicines Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Revolution Medicines Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Revolution Medicines Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Revolution Medicines Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Revolution Medicines Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Revolution Medicines Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Revolution Medicines Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Revolution Medicines Inc disclose its waste policy?
Sign up for free to unlockDoes Revolution Medicines Inc report according to TCFD requirements?
Sign up for free to unlockDoes Revolution Medicines Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Revolution Medicines Inc disclose energy use targets?
Sign up for free to unlockDoes Revolution Medicines Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Revolution Medicines Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Revolution Medicines Inc
These potential risks are based on the size, segment and geographies of the company.
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.